Acute Myelomonocytic Leukemia

Search Trials
A Study of E7820 in People With Bone Marrow (Myeloid) Cancers
Status:
Recruiting
Last Changed:
Apr 27, 2022
First Changed:
Aug 27, 2021
Disease(s):
Acute Myeloid Leukemia
Intervention(s):
E7820
Treosulfan-Based Versus Clofarabine-Based Conditioning Before Donor Hematopoietic Stem Cell Transplant for the Treatment of Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia
Status:
Not yet recruiting
Last Changed:
May 11, 2022
First Changed:
Aug 6, 2021
Disease(s):
Acute Myeloid Leukemia
Intervention(s):
ClofarabineFludarabineHematopoietic Cell TransplantationTotal-Body IrradiationTreosulfan
A Study of APG-2575 in Combination With Azacitidine in Patients With Acute Myeloid Leukemia (AML)
Status:
Recruiting
Last Changed:
May 25, 2022
First Changed:
Jul 16, 2021
Disease(s):
AML, Adult
Intervention(s):
APG 2575 ramp up arm
CPX-351 as a Novel Approach for the Treatment of Older Patients With AML and MDS
Status:
Recruiting
Last Changed:
Mar 16, 2022
First Changed:
Dec 16, 2020
Disease(s):
Refractory Acute Myeloid Leukemia
Intervention(s):
CPX-351
Fludarabine Phosphate, Cytarabine, Filgrastim-sndz, Gemtuzumab Ozogamicin, and Idarubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
Status:
Recruiting
Last Changed:
Oct 28, 2021
First Changed:
Dec 3, 2008
Disease(s):
Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11
Intervention(s):
CytarabineDecitabineFilgrastim-sndzFludarabine PhosphateGemtuzumab OzogamicinIdarubicinLaboratory Biomarker Analysis

Connect. Empower. Inspire.